Montag & Associates’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15 | Sell |
8
-1
| -11% | -$2 | ﹤0.01% | 944 |
|
|
2025
Q1 | $26 | Sell |
9
-5
| -36% | -$14 | ﹤0.01% | 992 |
|
|
2024
Q4 | $63 | Hold |
14
| – | – | ﹤0.01% | 992 |
|
|
2024
Q3 | $223 | Hold |
14
| – | – | ﹤0.01% | 1018 |
|
|
2024
Q2 | $388 | Buy |
14
+5
| +56% | +$139 | ﹤0.01% | 969 |
|
|
2024
Q1 | $339 | Buy |
9
+4
| +80% | +$151 | ﹤0.01% | 961 |
|
|
2023
Q4 | $126 | Hold |
5
| – | – | ﹤0.01% | 902 |
|
|
2023
Q3 | $153 | Hold |
5
| – | – | ﹤0.01% | 894 |
|
|
2023
Q2 | $159 | Hold |
5
| – | – | ﹤0.01% | 911 |
|
|
2023
Q1 | $238 | Hold |
5
| – | – | ﹤0.01% | 912 |
|
|
2022
Q4 | $225 | Hold |
5
| – | – | ﹤0.01% | 938 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 874 |
|
|
2022
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 789 |
|
|
2022
Q1 | $3K | Hold |
5
| – | – | ﹤0.01% | 771 |
|
|
2021
Q4 | $6K | Hold |
5
| – | – | ﹤0.01% | 759 |
|
|
2021
Q3 | $13K | Hold |
5
| – | – | ﹤0.01% | 707 |
|
|
2021
Q2 | $26K | Buy |
+5
| New | +$26K | ﹤0.01% | 636 |
|